Kymera Therapeutics KYMR 深 沪
等待开盘 10-29 09:30:00 美东时间
122.51
+4.940
+4.20%
华盛通- 最 高122.91
- 今 开116.17
- 成交量 76.82万股
- 最 低 115.46
- 昨 收 117.57
- 总市值 101.87亿
- 52周最高 130.05
- 市盈率 静 --
- 换手率 0.92%
- 52周最低 58.865
- 委 比 -66.67%
- 总股本 8315.06万
- 历史最高 130.05
- 量 比 1.04
- 振 幅 6.34%
- 历史最低 9.60
- 每 手 1
- 风险率 18.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅94.81%！富瑞上调ArriVent BioPharma(AVBP)目标价至30美元，维持"买入"评级
今日重点评级关注：富瑞：维持ArriVent BioPharma"买入"评级，目标价从18美元升至30美元；古根海姆：维持第一太阳能"买入"评级，目标价从282美元升至299美元
10-28 12:30
Kymera Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
Kymera Therapeutics, Inc. will report its third quarter 2026 financial results on October 29, 2026, and host a video conference call and webcast at 8:30 a.m. ET. Interested parties can join via the provided link or visit the "News and Events" section on the Company’s website. A replay of the webcast will be available post-event. Kymera is a clinical-stage biotech company advancing targeted protein degradation (TPD) to develop novel therapies for ...
10-22 20:01
美股大行评级 | 潜在涨幅91.5%！巴克莱上调Vertical Aerospace评级至"标配"，目标价下调至1美元
今日重点评级关注：巴克莱：上调Vertical Aerospace评级至"标配"，目标价从2美元降至1美元；巴克莱：维持Bitdeer Technologies"超配"评级，目标价从15美元升至17美元
10-12 14:52
This American Express Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BMO Capital analyst Andrew Bauch initiated coverage on American Express Co (NYSE:AXP) with an Out...
10-09 20:21
美股大行评级 | 瑞银维持康宁“买入”评级，上调目标价至201美元；大摩维持泛林集团“超配”评级
今日重点评级关注：Needham：维持iRhythm Holdings"买入"评级，目标价从192美元升至194美元；HC Wainwright & Co.：维持5E Advanced Materials"买入"评级，目标价从3.5美元升至6.75美元
10-06 16:45
Citigroup Maintains Buy on Kymera Therapeutics, Raises Price Target to $150
Citigroup analyst Geoff Meacham maintains Kymera Therapeutics (NASDAQ:KYMR) with a Buy and raises the price target from $135 to $150.
10-06 03:23
美股大行评级 | Muse热度发酵，Meta目标价获大幅升至875美元；闪迪获看好至2400美元，潜在升幅约27%
今日重点评级关注：Citizens：上调Quince Therapeutics评级至"跑赢大市"，目标价77美元；康托·菲茨杰拉德：维持塞德斯医疗"超配"评级，目标价从61美元升至72美元
09-23 15:30
Stifel Maintains Buy on Kymera Therapeutics, Raises Price Target to $152
Stifel analyst Alex Thompson maintains Kymera Therapeutics (NASDAQ:KYMR) with a Buy and raises the price target from $132 to $152.
09-22 18:43
美股大行评级 | 机构看淡消费股！麦当劳、耐克、卡夫亨氏齐遭降目标价；能源股获齐声唱多
今日重点评级关注：Ascendiant Capital：维持SurgePays"买入"评级，目标价从3.5美元升至3.75美元；HC Wainwright & Co.：维持Spero Therapeutics"买入"评级，目标价从5美元升至6美元
09-15 15:30
B of A Securities Maintains Buy on Kymera Therapeutics, Raises Price Target to $144
B of A Securities analyst Tazeen Ahmad maintains Kymera Therapeutics (NASDAQ:KYMR) with a Buy and raises the price target from $123 to $144.
09-15 01:47
